Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 511 - 520 of 742 studies

Cancer and neoplasms

CA266-0004: A Randomized Phase 2/3 Study of BMS-986545-01 (BNT327) in Combination with Chemotherapy Versus Standard of Care in Previously Untreated Participants with Unresectable, Metastatic, or Advanced Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Cancer and neoplasms

A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC whose tumor PD-L1 status is considered negative (ROSETTA-Breast)

Respiratory

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab adjunctive therapy in adult participants with COPD with type 2 inflammation characterized by an eosinophilic phenotype (ENDURA-2)

Musculoskeletal

An Open-label Extension Study to Investigate the Long term Safety, Tolerability, Pharmacokinetics, and Efficacy of WVE N531 in Patients with Duchenne Muscular Dystrophy Who Participated in Another Study of WVE N531 (WVE-N531-002)

DPYD polymorphisms in patients with solid tumours receiving fluoropyrimidines: A UK clinical registry

Infection Reproductive health and childbirth

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants (C1091009)

Cancer and neoplasms Metabolic and Endocrine

A PHASE 2/3, MULTICENTER, RANDOMIZED OPEN-LABEL STUDY OF ZANZALINTINIB VS EVEROLIMUS IN PARTICIPANTS WITH PREVIOUSLY TREATED, UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NEUROENDOCRINE TUMORS (XL092-311 (STELLAR-311))

Neurological

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Intravenous Prasinezumab In Participants With Early Parkinson’s Disease (BN44715 (PARAISO))

Respiratory

A Phase 2b/3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig compared with placebo in adult participants with moderate-to-severe chronic obstructive pulmonary disease with type 2 inflammation.. (PERSEPHONE)

United Kingdom Register of Stored Ovarian and Testicular Tissue (UKSTORE)